Literature DB >> 23569082

What is the best cryopreservation protocol for human testicular tissue banking?

Y Baert1, D Van Saen, P Haentjens, P In't Veld, H Tournaye, E Goossens.   

Abstract

STUDY QUESTION: Is there a better alternative to the conventional cryopreservation protocols for human testicular tissue banking? SUMMARY ANSWER: Uncontrolled slow freezing (USF) using 1.5 M dimethylsulphoxide (DMSO) and 0.15 M sucrose as cryoprotectants appears to be a user-friendly and efficient method for the cryopreservation of human testicular tissue. WHAT IS KNOWN ALREADY: Currently, time-consuming controlled slow freezing (CSF) protocols that need expensive equipment are commonly used for human testicular tissue banking. USF and vitrification are cryopreservation techniques that were successfully applied in several animal models but need further exploration with human tissue. STUDY DESIGN, SIZE, DURATION: Fragments (n = 160) of testicular tissue from 14 patients undergoing vasectomy reversal were assigned to a fresh control group or one of the following cryopreservation procedures: CSF using DMSO at a concentration of 0.7 or 1.5 M in the presence (+S) or absence of sucrose (-S), USF using either 0.7 or 1.5 M DMSO combined with sucrose, solid-surface vitrification (SSV) or direct cover vitrification (DCV). MATERIALS, SETTING,
METHODS: Light microscopic evaluations were performed to study apoptosis, germ cell proliferation ability, spermatogonial survival, coherence of the seminiferous epithelium and integrity of the interstitial compartment after cryopreservation. Ultrastructural alterations were studied by scoring cryodamage to four relevant testicular cell types. MAIN RESULTS AND THE ROLE OF CHANCE: The USF 1.5 M DMSO + S protocol proved not solely to prevent cell death and to preserve seminiferous epithelial coherence, interstitial compartment integrity, SG and their potential to divide but also protected the testicular cell ultrastructure. A significant reduction in the number of SG per tubule from 21.4 ± 5.6 in control tissue to 4.9 ± 2.1, 8.2 ± 5.4, 11.6 ± 5.1, 8.8 ± 3.9, 12.6 ± 4.4 and 11.7 ± 5.7 was observed after cryopreservation combined with at least one other form of cryoinjury when using CSF 0.7 M DMSO -S, CSF 0.7 M DMSO + S, CSF 1.5 M DMSO + S, USF 0.7 M DMSO + S, SSV and direct cover vitrification (DCV), respectively (P < 0.001). LIMITATIONS, REASONS FOR CAUTION: Supplementary research is required to investigate the effect on tissue functionality and to confirm this study's findings using prepubertal tissue. WIDER IMPLICATIONS OF THE
FINDINGS: An optimal cryopreservation protocol enhances the chances for successful fertility restoration. USF, being an easy and cost-effective alternative to CSF, would be preferable for laboratories in developing countries or whenever tissue is to be procured from a diseased child at a site distant from the banking facility.

Entities:  

Keywords:  cryopreservation; electron microscopy; germ cells; immunohistochemistry; male infertility

Mesh:

Substances:

Year:  2013        PMID: 23569082     DOI: 10.1093/humrep/det100

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  29 in total

Review 1.  [Androprotect and prospects for fertility treatment].

Authors:  S Kliesch
Journal:  Urologe A       Date:  2016-07       Impact factor: 0.639

2.  A comparison between a new vitrification protocol and the slow freezing method in the cryopreservation of prepubertal testicular tissue.

Authors:  Moacir R M Radaelli; Carlos G Almodin; Vânia C Minguetti-Câmara; Paula Motta Almodin Cerialli; Aissar E Nassif; Antonio J Gonçalves
Journal:  JBRA Assist Reprod       Date:  2017-09-01

Review 3.  Experimental methods to preserve male fertility and treat male factor infertility.

Authors:  Kathrin Gassei; Kyle E Orwig
Journal:  Fertil Steril       Date:  2015-12-30       Impact factor: 7.329

4.  Fertility Preservation Options for Men and Women With Cancer.

Authors:  Malgorzata E Skaznik-Wikiel; Sara Babcock Gilbert; Randall B Meacham; Laxmi A Kondapalli
Journal:  Rev Urol       Date:  2015

5.  Developmental Potential of Vitrified Mouse Testicular Tissue after Ectopic Transplantation.

Authors:  Nazila Yamini; Gholamreza Pourmand; Fardin Amidi; Mojdeh Salehnia; Nahid Ataei Nejad; Seyed Mohammad Mougahi
Journal:  Cell J       Date:  2016-04-04       Impact factor: 2.479

6.  Histologic Analysis of Testes from Prepubertal Patients Treated with Chemotherapy Associates Impaired Germ Cell Counts with Cumulative Doses of Cyclophosphamide, Ifosfamide, Cytarabine, and Asparaginase.

Authors:  Jose V Medrano; D Hervás; T Vilanova-Pérez; A Navarro-Gomezlechon; E Goossens; A Pellicer; M M Andrés; E Novella-Maestre
Journal:  Reprod Sci       Date:  2020-11-04       Impact factor: 3.060

Review 7.  Strategies for cryopreservation of testicular cells and tissues in cancer and genetic diseases.

Authors:  Tanushree Patra; Devendra Pathak; Mukesh Kumar Gupta
Journal:  Cell Tissue Res       Date:  2021-04-01       Impact factor: 5.249

Review 8.  Pediatric and Adolescent Oncofertility in Male Patients-From Alpha to Omega.

Authors:  Ovidiu Bîcă; Ioan Sârbu; Carmen Iulia Ciongradi
Journal:  Genes (Basel)       Date:  2021-05-08       Impact factor: 4.096

9.  Cryopreservation of testis tissues and in vitro spermatogenesis.

Authors:  Tetsuhiro Yokonishi; Takehiko Ogawa
Journal:  Reprod Med Biol       Date:  2015-08-05

Review 10.  Fertility preservation during cancer treatment: clinical guidelines.

Authors:  Kenny A Rodriguez-Wallberg; Kutluk Oktay
Journal:  Cancer Manag Res       Date:  2014-03-04       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.